3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials.
Pharmacol Res
; 156: 104779, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-26870
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Protease Inhibitors
/
Clinical Trials as Topic
/
Viral Nonstructural Proteins
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Pharmacol Res
Journal subject:
Pharmacology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS